Diatrizoate
Trade name: gastrografin
Small moleculeexperimental
Diatrizoate, also known as amidotrizoate, Gastrografin, is a contrast agent used during X-ray imaging. This includes visualizing veins, the urinary system, spleen, and joints, as well as computer tomography. It is given by mouth, injection into a vein, injection into the bladder, through a nasogastric tube, or rectally. — Wikipedia
Clinical trial activity
12 trials · 18 clinical orgs · 0 marketing orgs
Phase 1
0
Phase 2
4
Phase 3
4
Phase 4
5
Earliest trial started Sep 1, 2003 (NCT00601809)
Timeline
Indications
Approved for
Studied for
- Colonic Neoplasms · Phase 3
- Colonic Polyps · Phase 3
- Congenital Abnormalities · Phase 4
- Fecal Impaction · Phase 2
- Gastroschisis · Phase 4
- Hemorrhage · Phase 3
- Infant, Very Low Birth Weight · Phase 4
- Inflammatory Bowel Diseases · Phase 3
- Intestinal Diseases · Phase 4
- Intestinal Neoplasms · Phase 4
- Meconium Ileus · Phase 4
- Postoperative Complications · Phase 4
- Urethral Diseases · Phase 3
Mechanism of action
- Unspecified targetRadiopaque
radiopaque
Chemistry & pharmacology
Oral
No
Parenteral
No
Topical
No
Sources
- WikipediaDiatrizoate ↗
Also known as
- gastrografin
- gastrografin
- gastrografin
- urografin
- urografin
Clinical trials
| NCT ID | Phase | Start date | Sponsor(s) |
|---|---|---|---|
| NCT06182319 | Phase 3 | Dec 15, 2023 | University of California, Los Angeles |
| NCT05726097 | Phase 3 | Feb 1, 2023 | Lund University, Region Skane, University of Southern Denmark |
| NCT03334578 | Phase 4 | Aug 3, 2018 | University of Western Ontario |
| NCT02344654 | N/A | May 1, 2015 | University of Copenhagen |
| NCT02784093 | Phase 2 | Apr 1, 2015 | Jinlin University, Nanjing University |
| NCT03642288 | N/A | Apr 1, 2014 | Jinlin University |
| NCT01790776 | Phase 3 | Feb 1, 2013 | Ghent University |
| NCT01648972 | Phase 2/Phase 3 (Phase 3) | Sep 1, 2012 | University of Auckland |
| NCT01440712 | Phase 4 | Dec 1, 2011 | University of Barcelona |
| NCT01515696 | Phase 4 | Oct 1, 2007 | Medical University of Vienna, University of Vienna |
| NCT00389116 | Phase 4 | Nov 1, 2006 | Centre Hospitalier de Beauvais, Rouen Normandy University, University of Picardie Jules Verne |
| NCT00601809 | Phase 4 | Sep 1, 2003 | University of Bologna, University of Modena and Reggio Emilia |
Showing 12 of 12 trials
Page 1 / 1
Organizations
Research & Development (18)
| Organization | Org type | Trials | As lead sponsor | Phases | Earliest year |
|---|---|---|---|---|---|
| Jinlin University | Academic/Hospital | 2 | 2 | 2 | 2014 |
| Centre Hospitalier de Beauvais | Academic/Hospital | 1 | 0 | 1 | 2006 |
| Ghent University | Academic/Hospital | 1 | 1 | 1 | 2013 |
| Lund University | Academic/Hospital | 1 | 0 | 1 | 2023 |
| Medical University of Vienna | Academic/Hospital | 1 | 1 | 1 | 2007 |
| Nanjing University | Academic/Hospital | 1 | 0 | 1 | 2015 |
| Region Skane | Government | 1 | 1 | 1 | 2023 |
| Rouen Normandy University | Academic/Hospital | 1 | 1 | 1 | 2006 |
| University of Auckland | Academic/Hospital | 1 | 1 | 1 | 2012 |
| University of Barcelona | Academic/Hospital | 1 | 1 | 1 | 2011 |
| University of Bologna | Academic/Hospital | 1 | 1 | 1 | 2003 |
| University of California, Los Angeles | Academic/Hospital | 1 | 1 | 1 | 2023 |
| University of Copenhagen | Academic/Hospital | 1 | 1 | 1 | 2015 |
| University of Modena and Reggio Emilia | Academic/Hospital | 1 | 0 | 1 | 2003 |
| University of Picardie Jules Verne | Academic/Hospital | 1 | 0 | 1 | 2006 |
| University of Southern Denmark | Academic/Hospital | 1 | 0 | 1 | 2023 |
| University of Vienna | Academic/Hospital | 1 | 0 | 1 | 2007 |
| University of Western Ontario | Academic/Hospital | 1 | 1 | 1 | 2018 |
18 organizations
Page 1 / 1